Russia rises among trial sites; Aptuit shakes up management;

> Russia is on the rise among European clinical trial sites. Article

> Telrx has bought up Sentrx Safety Solutions, a provider of pharmacovigilance testing services. Story

> CRO Ergomed has signed on to handle a Phase III study for Aeterna Zentaris, a deal that gives the company a sharge of future drug profits. News

> Cyclica and Dalton have united to identify and develop new drug candidates. More

> Aptuit has appointed a new CFO and vice president for business development. Report

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.